IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in IGC Pharma, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −4 vs. Q3 2025
- Shares held
- 4.83M
- −589.6K (−10.9%) vs. Q3 2025
- Total value
- $1.36M
- −$899.2K (−39.8%) vs. Q3 2025
- New holders
- 5
- 5 more added
- Sold out
- 9
- 5 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $1.41M |
| Q1 2026 | 35 | $1.14M |
| Q4 2025 | 30 | $1.36M |
| Q3 2025 | 35 | $2.27M |
| Q2 2025 | 28 | $929.4K |
| Q1 2025 | 25 | $814.9K |
| Q4 2024 | 30 | $954.3K |
| Q3 2024 | 23 | $1.19M |
| Q2 2024 | 25 | $1.11M |
| Q1 2024 | 25 | $943.4K |
| Q4 2023 | 25 | $691.3K |
| Q3 2023 | 27 | $1.01M |
| Q2 2023 | 23 | $827.5K |
| Q1 2023 | 23 | $917.6K |
| Q4 2022 | 26 | $937.3K |
| Q3 2022 | 26 | $1.31M |
| Q2 2022 | 29 | $1.73M |
| Q1 2022 | 29 | $3.97M |
| Q4 2021 | 29 | $6.07M |
| Q3 2021 | 32 | $7.90M |
| Q2 2021 | 29 | $7.90M |
| Q1 2021 | 29 | $7.97M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Triumph Capital Management | 2 | $1 | 0.00% | +2 | New |
| DHJJ Financial Advisors, Ltd. | 80 | $23 | 0.00% | 00.0% | Unchanged |
| Hurley Capital, LLC | 100 | $28 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 100 | $28 | 0.00% | 00.0% | Unchanged |
| Root Financial Partners, LLC | 100 | $28 | 0.00% | +100 | New |
| Jones Financial Companies LLLP | 110 | $31 | 0.00% | +110 | New |
| Caitlin John, LLC | 200 | $56 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 655 | $184 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,808 | $508 | 0.00% | −2,150−54.3% | Reduced |
| Geneos Wealth Management Inc. | 3,000 | $840 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 7,187 | $2.02K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 14,392 | $4.05K | 0.00% | +4,599+47.0% | Added |
| Morgan Stanley | 17,707 | $4.98K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 19,869 | $5.58K | 0.00% | +16,824+552.5% | Added |
| T3 Companies, LLC | 20,000 | $5.63K | 0.01% | +20,000 | New |
| XTX Topco Ltd | 28,324 | $7.97K | 0.00% | −5,679−16.7% | Reduced |
| Commonwealth Equity Services, LLC | 33,348 | $9.38K | 0.00% | −1,600−4.6% | Reduced |
| Truist Financial Corp | 36,667 | $10.3K | 0.00% | 00.0% | Unchanged |
| Fisher Asset Management, LLC | 43,400 | $12.2K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 65,541 | $18.4K | 0.00% | 00.0% | Unchanged |
| Lawood & Co | 75,000 | $21.1K | 0.02% | +75,000 | New |
| Dearborn Partners LLC | 84,401 | $23.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 113,407 | $31.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 154,959 | $43.6K | 0.00% | +140,997+1,009.9% | Added |
| State Street Corp | 200,799 | $56.5K | 0.00% | +40,592+25.3% | Added |
| Citadel Advisors LLC | 277,594 | $78.1K | 0.00% | −350,246−55.8% | Reduced |
| BlackRock, Inc. | 703,798 | $198.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 860,477 | $242.2K | 0.00% | +8,033+0.9% | Added |
| Renaissance Technologies LLC | 919,641 | $258.8K | 0.00% | −299,324−24.6% | Reduced |
| Vanguard Group Inc | 1,149,268 | $322.9K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −89,546−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −60,258−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −35,028−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −27,821−100.0% | Sold out |
| Thompson Davis & Co., Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −13,961−100.0% | Sold out |
| Evermay Wealth Management LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −212−100.0% | Sold out |
| Wolverine Trading, LLC | – | – | – | – | Not filed |